Back to results
US 12,275,759 B2Granted
Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same
AssigneeRiken
InventorKenji Ogawa
Life of this patent
Estimating the term…
Abstract
The purpose of the invention is to develop and provide a novel therapeutic agent for hepatitis B that differs from the conventional therapeutic agent for hepatitis B in the mechanism of action, or target of interest. Provided is an inhibitor of hepatitis B virus replication consisting of a spike region in the core protein of a hepatitis B virus, or an expression vector containing a nucleic acid encoding the same.
Claims3
A method for inhibiting hepatitis B virus replication comprising introducing into a host a peptide fragment constituting a spike region in a core protein of a hepatitis B virus:
- wherein said peptide fragment constituting the spike region consists of the amino acid sequence corresponding to SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.